Researchers from the Abramson Cancer Center of the University of Pennsylvania have found that liquid biopsy can help to predict the prognosis of glioblastoma(GBM), the most aggressive and common brain cancer in adults.

Immuno-Transcriptomics firm Novigenix has received positive results from its early colon cancer detection blood test at the European Society for Medical Oncology (ESMO) 2019.

Advances in cancer treatments, such as immunotherapies and precision medicines, have been associated with a corresponding rise in the cost of new and innovative medicines.

A research team led by the University of Strathclyde in the UK has developed an artificial intelligence (AI)-based blood test for the diagnosis of brain cancer.

UK-based online therapy provider Ieso Digital Health has applied deep learning to provide new insights into which aspects of psychotherapy are the most effective.

Researchers at Stanford University in the US have developed new sensors that can be adhered to the skin for wireless monitoring of health. The sensors are designed to identify the physiological signals that the skin emanates, such as pulse. These readings will be wirelessly transmitted to a receiver clipped onto clothing. The sensor and receiver system has been named BodyNet.

Researchers at the University of Washington have developed a new contactless artificial intelligence (AI) tool to monitor at-risk patients for cardiac arrest, even when they're asleep.

3D printing solutions provider Materialise has obtained clearance for its Mimics Enlight cardiovascular planning software suite from the US Food and Drug Administration (FDA).

Patient enrolment has begun on Biotronik's study of its new Acticor and Rivacor range of cardiac rhythm management (CRM) devices.